Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 72% · fresh
- Computed at
- 2026-07-21T20:38:48.207486+00:00
- Claimed
- 80
- Reported
- 79
- Verified
- 73
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Critical
Decision
What the current evidence supports
Human editorial judgment · 2026-07-21
Track; not yet
- Why
- FDA has only accepted the BLA for review (not approved); the accelerated-approval pathway rests on an unconfirmed surrogate endpoint with no prior exon-skipping ASO in this class having completed a confirmatory trial, so clinical benefit remains unproven pending the ongoing FORZETTO Phase 3.
- Next
- Re-check at PDUFA action (2027-01-21) for FDA approval decision and any released DELIVER trial numeric efficacy/safety data; escalate to 'Adopt with guardrails' framing only after accelerated approval is granted and functional-endpoint data are public.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 5
- Tier 3
- 1
- Supports
- 3
- Contradicts
- 1
- Context
- 2
- Latest observed
- 2026-07-20
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-21 Reading moved from ready to ready.